Pregabalin Capsule
Product Images NDC 50228-357
Product Visual Gallery
This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 50228-357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sciegen Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Pregabalin Str)
Figure 1 (Pregabalin Fig01)
Figure 2 (Pregabalin Fig02)
Figure 3 (Pregabalin Fig03)
Figure 4 (Pregabalin Fig04)
Figure 5 (Pregabalin Fig05)
Figure 6 (Pregabalin Fig06)
Figure 7 (Pregabalin Fig07)
Figure 13 (Pregabalin Fig13)
Figure 9 (Pregabalin Fig08)
Figure 10 (Pregabalin Fig09)
Figure 11 (Pregabalin Fig10)
Figure 12 (Pregabalin Fig11)
Principal Display Panel (25 mg Capsule Bottle Label)
Principal Display Panel (25 mg Capsule Bottle)
Principal Display Panel (25 mg Capsule Blister Pack)
Principal Display Panel (50 mg Capsule Blister Pack Carton)
Principal Display Panel (50 mg Capsule Blister Pack)
Principal Display Panel (50 mg Capsule Bottle Label)
Principal Display Panel (75 mg Capsule Blister Pack)
Principal Display Panel (75 mg Capsule Blister Pack)
Principal Display Panel (75 mg Capsule Blister Pack Carton)
Principal Display Panel (100 mg Capsule Bottle Label)
Principal Display Panel (100 mg Capsule Bottle)
Principal Display Panel (100 mg Capsule Blister Pack)
Principal Display Panel (150 mg Capsule Blister Pack Carton)
Principal Display Panel (150 mg Capsule Blister Pack Carton)
Principal Display Panel (150 mg Capsule Bottle Label)
Principal Display Panel (200 mg Capsule Blister Pack)
Principal Display Panel (200 mg Capsule Blister Pack)
Principal Display Panel (200 mg Capsule Blister Pack Carton)
Principal Display Panel (225 mg Capsule Bottle Label)
Principal Display Panel (225 mg Capsule Bottle Label)
Principal Display Panel (225 mg Capsule Bottle Label)
Principal Display Panel (300 mg Capsule Bottle Label)
Principal Display Panel (300 mg Capsule Bottle Label)
Principal Display Panel (300 mg Capsule Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.